[1]
X. Feng, S. Zhu, Z. Yan, C. Wang, W. Tong, and W. Xu, “PDGFRB as a potential therapeutic target of ankylosing spondylitis: validation following bioinformatics analysis”, Cell Mol Biol (Noisy-le-grand), vol. 66, no. 6, pp. 127–134, Sep. 2020.